NCT02762513View on ClinicalTrials.gov

Expansion Trial for Axitinib In Head And Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 30, 2016

Primary Completion Date

April 9, 2020

Study Completion Date

April 9, 2020

Conditions
Squamous Cell Carcinoma of the Head and Neck
Interventions
DRUG

Axitinib

Trial Locations (1)

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

National Comprehensive Cancer Network

NETWORK

lead

University of Michigan Rogel Cancer Center

OTHER

NCT02762513 - Expansion Trial for Axitinib In Head And Neck Cancer | Biotech Hunter | Biotech Hunter